{
    "Trade/Device Name(s)": [
        "HemosIL dRVVT Screen",
        "HemosIL dRVVT Confirm"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K110031",
    "Predicate Device Reference 510(k) Number(s)": [
        "K990302"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GIR",
        "GGC"
    ],
    "Summary Letter Date": "August 16, 2011",
    "Summary Letter Received Date": "August 19, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.8950"
    ],
    "Regulation Name(s)": [
        "Russell Viper Venom Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Lupus anticoagulant"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [
        "Sodium citrate tube (3.2%, 3.8%)"
    ],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family",
        "ACL TOP 500 CTS"
    ],
    "Method(s)/Technology(ies)": [
        "Diluted Russell's viper venom clotting assay"
    ],
    "Methodologies": [
        "Clotting assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL dRVVT Screen and dRVVT Confirm qualitative assays for detecting lupus anticoagulant in citrated plasma using the diluted Russell's viper venom method.",
    "Indications for Use Summary": "Qualitative in-vitro assays aiding in detection of lupus anticoagulants in human citrated plasma for patients with unexplained prolonged APTT, to be used in parallel as an integrated test on the ACL TOP Family.",
    "fda_folder": "Hematology"
}